BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 4447441)

  • 21. [Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].
    Stekar J
    Arzneimittelforschung; 1976; 26(10):1793-7. PubMed ID: 191035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment experiments with glucose-induced hyperglycaemia plus Clostridium-spores on the Jensen sarcoma of rats].
    Hambsch K; Körner C; Ludewig R
    Arch Geschwulstforsch; 1982; 52(4):267-73. PubMed ID: 7138239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antitumor activity and preclinical pharmacologic evaluation of pingyangmycin (author's transl)].
    Lin FT; Li DD; Yang XP; Li Q; Xue YC; Zhen YS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):161-6. PubMed ID: 95444
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy for tumours using clostridial oncolysis, antibiotics and cyclophosphamide: model trial on the UVT 15264 tumour.
    Schlechte H; Schwabe K; Mehnert WH; Schulze B; Bräuniger H
    Arch Geschwulstforsch; 1982; 52(1):41-8. PubMed ID: 7082130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigations on the characterization of a clostridial strain for tumour diagnosis (author's transl)].
    Schau HP; Fabricius EM; Schneeweiss U; Benedix A
    Zentralbl Bakteriol A; 1980 Feb; 246(1):80-97. PubMed ID: 7424236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of 5-fluorouracil on the healing of stomach wounds].
    Gzovskaia ON
    Farmakol Toksikol; 1973; 36(3):352-5. PubMed ID: 4788502
    [No Abstract]   [Full Text] [Related]  

  • 29. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

  • 31. [The behaviour of clostridium butyricum in the early Ehrlich-carcinoma of the mouse-investigations on the tumour-clostridium-phenomenon (author's transl)].
    Urban S; Wildner GP; Schneeweiss U; Fabricius EM
    Arch Geschwulstforsch; 1974; 43(1):8-15. PubMed ID: 4603881
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxicity and antineoplastic activity of a new thio-TEPA analog].
    Konovalova NP; D'iachkovskaia RF; Kiseleva EG
    Vopr Onkol; 1973; 19(1):58-63. PubMed ID: 4349733
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serological studies using clostridial spores for tumor diagnosis. I. Transplantable tumors in rats and hamsters].
    Kretschmer H; Grässer A
    Arch Geschwulstforsch; 1973; 41(1):12-7. PubMed ID: 4700691
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental antitumor activity and preclinical toxicology of mycophenolic acid.
    Sweeney MJ; Gerzon K; Harris PN; Holmes RE; Poore GA; Williams RH
    Cancer Res; 1972 Sep; 32(9):1795-802. PubMed ID: 4509039
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
    Schmid FA; Otter GM; Stock CC
    Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of the DS-carcinosarcoma in the rat with ifosfamide/dimethylsulfoxide].
    von Ardenne M; Reitnauer PG
    Pharmazie; 1975 Sep; 30(9):602-5. PubMed ID: 1187742
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of immunity in the action of sarcolysine and other preparations].
    Syrkin AB; Solenov VN; Bodiagin DA; Zaĭtseva LA
    Vestn Akad Med Nauk SSSR; 1971; 26(3):55-9. PubMed ID: 5581445
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
    Gold J
    Oncology; 1973; 27(1):69-80. PubMed ID: 4739164
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiments to improve the oncolysis-effect of clostridial-strain M55 (author's transl)].
    Möse JR
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):541-5. PubMed ID: 543354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.